These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 658086)

  • 1. Sequential studies of melanoma leukocyte-dependent antibody activity in melanoma patients.
    Hersey P; Edwards AE; Murray E; McCarthy WH; Milton GW
    Eur J Cancer (1965); 1978 Jun; 14(6):629-37. PubMed ID: 658086
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of leukocyte-dependent antibody activity in melanoma patients.
    Hersey P; Edwards A; Murray E; McCarthy WH; Milton GW
    J Natl Cancer Inst; 1983 Jul; 71(1):45-53. PubMed ID: 6575208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.
    Murray E; McCarthy WH; Hersey P
    Br J Cancer; 1977 Jul; 36(1):7-14. PubMed ID: 19029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human melanoma antigens in cell-free supernatants.
    Leong SP; Cooperband SR; Sutherland CM; Krementz ET; Deckers PJ
    J Surg Res; 1978 Apr; 24(4):245-52. PubMed ID: 347171
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological studies on malignant melanomas of man.
    Romsdahl MM; Cox IS
    Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
    [No Abstract]   [Full Text] [Related]  

  • 7. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.
    Gupta RK; Morton DL
    Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking factors against melanoma leucocyte-dependent antibody: relationship to disease activity in melanoma patients.
    Hersey P; Murray E; Ruygrok S; Edwards A; Milton GW
    Aust N Z J Surg; 1978 Feb; 48(1):26-32. PubMed ID: 276346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens.
    McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients.
    Murray E; Ruygrok S; Milton GW; Hersey P
    Int J Cancer; 1978 May; 21(5):578-87. PubMed ID: 350780
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of the immunology working party of the EORTC melanoma group.
    Rümke P
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):839-41. PubMed ID: 7037425
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
    Luo W; Ko E; Hsu JC; Wang X; Ferrone S
    J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic aspects of melanoma.
    Carey TE
    Crit Rev Clin Lab Sci; 1982; 18(2):141-82. PubMed ID: 6295700
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.